They also reduce cardiovascular events that compete with cancerspecific risks, suggesting a dual pathway to improved survival. As for the next steps of this research, Cuomo said first is a randomized, controlled evaluation of GLP1 RAs as an adjunct to standard colon cancer therapy, stratified by body mass index (BMI) and timed relative to surgery and systemic therapy
But ~25% is a defensible midpoint, not a stretch
Trials involving dual-acting GLP-1 and glucose-dependent insulinotropic polypeptide receptor agonists or surrogate outcomes were excluded
Further studies are needed to assess the potential benefit of riboflavin supplementation in reducing perinatal complications generally and specifically in preeclamptic women with the MTHFR 677TT genotype
Pregnant women should receive an inactivated or recombinant influenza vaccine
In such cases, starting an oral GLP-1 medication may reduce hesitation and improve early engagement with therapy